COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter study
- Spyros A. Papiris1,
- Ilaria Campo2,
- Francesca Mariani2,
- Maria Kallieri1,
- Lykourgos Kolilekas3,
- Andriana I Papaioannou1,
- Efsun Gonca Chousein4,
- Erdogan Cetinkaya4,
- Francesco Bonella5,
- Raphael Borie6,
- Maria Kokosi7,
- Thomas Pickworth8,
- Maria Molina-Molina9,
- Mercè Gasa9,
- Elżbieta Radzikowska10,
- Justyna Fijolek10,
- Stéphane Jouneau11,
- Emmanuel Gomez12,
- Cormac McCarthy13,
- Elisabeth Bendstrup14,
- Wojciech J. Piotrowski15,
- Rishi Pabary16,
- Alice Hadchouel17,
- Nathalie Coolen-Allou18,
- Tiago Alfaro19,
- Carlos Robalo Cordeiro19,
- Elvira-Markela Antonogiannaki1,
- Ioannis P. Tomos1,
- Despoina Papakosta20,
- Theodoros Kontakiotis20,
- Panagiota Panagiotou21,
- Konstantinos Douros22,
- Andrea Schams23,
- Sara Lettieri2,
- Vassiliki Papaevangelou22,
- Christina Kanaka-Gantenbein21,
- Anna Karakatsani1,
- Stelios Loukides1,
- Ulrich Costabel5,
- Bruno Crestani6,
- Cliff Morgan7,
- Ryushi Tazawa24,
- Andrew Bush16,
- Matthias Griese23 and
- Effrosyni D. Manali1⇑
- 1General University Hospital “Attikon”, Medical School, National and Kapodistrian University of Athens, Greece.
- 2Laboratorio di Biochimica e Genetica, U.O.C. Pneumologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- 3Dr Lykourgos Kolilekas, 7th Pulmonary Department, Athens Chest Hospital “Sotiria”, Athens Greece
- 4University of Health Sciences Turkey, Yedikule Chest Diseases and Thoracic Surgery Research and Training Hospital, İstanbul, Turkey
- 5Center for Interstitial and Rare Lung Diseases, Pneumology Department, Ruhrlandklinik, University Hospital, University of Essen, Essen, Germany; European Reference Network (ERN)-LUNG, ILD Core Net, Francesco
- 6Université de Paris, INSERM UMR 1152, Paris, France, APHP, Hôpital Bichat, Service de Pneumologie A, FHU APOLLO, Centre de référence des maladies pulmonaires rares, Paris, France
- 7Interstitial Lung Disease Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK; Interstitial Lung Disease Unit, Guy's and St Thomas’ Hospital NHS Foundation Trust, Great Maze Pond, London, UK
- 8Department of Anaesthesia, Royal Brompton Hospital, London, UK
- 9ILD Multidisciplinary Unit Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain
- 103rd Department of Lung Diseases and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
- 11IRSET UMR 1085, Université de Rennes Service de Pneumologie, CHU de Rennes, France
- 12Pneumologie, CHU de Nancy
- 13University College Dublin School of Medicine Education and Research Centre, St. Vincent's University Hospital, Dublin 4, Ireland
- 14Center for Rare Lung diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Denmark
- 15Department of Pneumonology, 2nd Chair of Internal Medicine, Medical University of Lodz, Lodz
- 16Paediatrics and Paediatric Respirology, Imperial College, UK; Imperial Centre for Paediatrics and Child Health, UK, Royal Brompton Harefield NHS Foundation Trust, London, UK
- 17AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de l'Enfant, Paris, France, INSERM U1151, Institut Necker Enfants Malades, Paris, France, Université de Paris, Faculté de Médecine, Paris, France
- 18Service de Pneumologie Hôpital Félix Guyon, CHU Réunion
- 19Department of Pulmonology, Coimbra Univesrity Hospital, Univesrity of Coimbra, Portugal
- 20A Department of Pulmonary Medicine, Aristotle University of Thessaloniki, “G. Papanikolaou” Hospital, Exochi, Thessaloniki, Greece
- 21First Department of Paediatrics, Agia Sophia Children's Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 22Third Department of Pediatrics “Attikon” University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- 23Department of Pediatric Pneumology, Dr von Hauner Children's Hospital, Ludwig-Maximilians-University, German Center for Lung Research, Munich, Germany
- 24Health Administration Center, Tokyo Medical and Dental University, Tokyo, Japan
- Corresponding author: Effrosyni Manali (fmanali{at}otenet.gr)
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Papiris reports grants, personal fees and non-financial support from La Roche Hoffman , grants, personal fees and non-financial support from Boehringer Ingelheim , other from SAVARA , outside the submitted work.
Conflict of interest: Dr. Bonella reports grants and personal fees from Savara Pharma, outside the submitted work.
Conflict of interest: Raphael Borie has received consulting fees from Boerhinger Ingelheim, Roche, and Sanofi, outside the submitted work. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boerhinger Ingelheim and Roche, outside the submitted work. Support for attending meetings and/or travel received from Boerhinger Ingelheim, Roche, and Chiesim outside the submitted work. Participation on a Data Safety Monitoring Board or Advisory Board for SAvara, outside the submitted work.
Conflict of interest: Dr. MOLINA MOLINA reports personal fees and grants from Esteve-Teijin, Roche, and Boehringer Ing., outside the submitted work.
Conflict of interest: Dr. Bendstrup reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Hofmann la Roche, personal fees from Galapagos, outside the submitted work.
Conflict of interest: Dr. Jouneau reports personal fees and other from Actelion, personal fees and other from AIRB, personal fees and other from AstraZeneca, personal fees and other from Bellerophon Therapeutics, personal fees and other from Biogen, personal fees and other from BMS, personal fees and other from Boehringer Ingelheim, personal fees and other from Chiesi, personal fees and other from FibroGen, personal fees and other from Galecto Biotech, personal fees and other from Genzyme, personal fees and other from Gilead, personal fees and other from GlaxoSmithKline, personal fees and other from LVL, personal fees and other from Mundipharma, personal fees and other from Novartis, personal fees and other from Pharm-Olam, personal fees and other from Pfizer, personal fees and other from Pliant Therapeutics, personal fees and other from F. Hoffmann-La Roche, Ltd., personal fees and other from Sanofi, personal fees and other from Savara-Serendex, outside the submitted work.
Conflict of interest: Dr. McCarthy reports and Scientific advisory board member of Savara Inc. Unrelated to this work and have not received any payment from Savara Inc for any work to date.
Conflict of interest: Matthias Griese has received grants or contracts from Böhringer Ingelheim, outside the submitted work. Participation on a Data Safety Monitoring Board or Advisory Board for Böhringer Ingelheim, outside the submitted work. Leadership or fiduciary role in other board, society, committee or advocacy group, unpaid for Head chILD-EU, outsde the submitted work.
Conflict of interest: Dr. MANALI reports personal fees and non-financial support from La Roche Hoffman , grants, personal fees and non-financial support from Boehringer Ingelheim , other from SAVARA , outside the submitted work.
Conflict of interest: The remaining authors have nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©The authors 2022
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org